Vaccines Market, By Type (Inactivated, Attenuated, Toxoid, Recombinant Vector, Subunit, DNA, and Conjugate Vaccines), By Application (Allergy, Cancer, Infectious Disease, and Autism) and By Geography (NA, EU, APAC, LATAM and MEA) Trends, & Forecast Analysis From 2020 2026
REPORT HIGHLIGHT
The vaccines market was valued at USD XX billion by 2019, growing with XX% CAGR during the forecast period, 2020-2026
Market Dynamics
Vaccines play a major role in maintaining better health of people across different regions of the world. Thus, vaccines are employed to prevent several diseases by strategies according to regions. Over the past few years, the increase in the occurrence of bacterial, viral, and infectious diseases has surged the demand for vaccines or vaccinations. Essentially directed to the people of different age groups, vaccinations help in strengthening the immune system and also protect from several infectious diseases.
The high-level benefits of immunization and the growing demand for better healthcare infrastructure are the significant factors boosting the industry growth. The governments of both developed and developing countries are taking initiatives by granting access to immunization for every person in society. The World Health Organization (WHO) in May 2012, launched the ‘GVAP’ (Global Vaccine Action Plan). Around 194 state members of the World Health Assembly authorized this plan prior to its launch. The WHO and UNICEF have together published the guidelines or the Multi-Year Plan by developing a national immunization plan for all regions around the globe. This gradually rising global immunization has led to the profitable growth of the market. However, in developing countries, there is inadequate access to vaccines which is considered a major threat to the growth of the global vaccines market. Along with this, a strict regulatory process also pushes back the development of new vaccines, which is a big challenge for the vaccine industry.
Types Takeaway
On the basis of type, the worldwide market is segmented into recombinant vector, conjugate, inactivated, toxoid, attenuated, subunit, and DNA vaccines. Of these, the segment for inactivated vaccines is projected to dominate the market throughout the forecast period. This segmented is expected to rise at a CAGR of XX% by 2026, mainly due to the benefits such as high stability and long shelf-life are associated with this type of vaccines. On the other, the DNA vaccines segment is expected to be the fastest in terms of growth during the period of forecast. The chief reason for this robust growth is the reduced risk of integration and its high specificity than other traditional vaccines.
In Phase III clinical trials, the vaccinations that are under development process include HZ/su or Herpes Zoster Subunit. This a recombinant version of the vaccine turned out to be successful in 51% of tested adults that are above 60 years of age. However, the effectiveness of HZ/su is observed to decrease with age. Moreover, the Research Foundation of Oklahoma and Merck & Co. Inc., are now collaboratively researching to develop the CAD106 and therapeutic Alzheimer’s disease vaccine, which is currently under phase II clinical trials.
Application Takeaway
On the basis of application, the global vaccines market is categorized into cancer, infectious diseases, and allergy. The infectious diseases segment is anticipated to hold the largest market share during the forecast period. As infectious diseases are the main cause of morbidity and mortality, people’s concerns are rising regarding immunization. This will drive the growth of the vaccine market in the years to come.
On the other hand, the growing occurrence of severe diseases, such as hepatitis, cholera, measles, typhoid, chickenpox, and several other diseases has resulted in rising demand for vaccines to immunize against these diseases. Moreover, several molecular entities are developing novel and improved vaccines to target fatal diseases such as Ebola, AIDS, Hepatitis C, Chagas, and many more.
Regional Takeaway
Geographically, the global market for vaccines is divided into North America, Asia Pacific, Europe, LATAM, and MEA. North America vaccines market is estimated to generate a revenue of USD XX billion by the end of 2026. This segment is likely to grow at a steady pace owing to government support for vaccine development and the major market investors are located in this region. Moreover, the most advanced medical facilities and healthcare infrastructure present in the North America region are key factors supporting the advent of this vertical. On the other hand, the Asia Pacific market for vaccines is predicted to rise at a CAGR of XX% from 2020 to 2026. This growth is attributed to the rising target population coupled with high-unmet medical needs in this region.
Key Vendor Takeaway
Some of the key players that are actively responsible for the growth of the vaccines market include Johnson and Johnson, Merck &Co., Inc., Sanofi Pasteur, Inc., Emergent BioSolutions, Inc., Novartis AG, Pfizer, Inc., GlaxoSmithKline Plc., and CSL Ltd. Other prominent players include AstraZeneca Plc, Abbott Laboratories, Takeda Pharmaceuticals Company Ltd., Janssen Pharmaceuticals, Inc., and Valeant Pharmaceuticals International, Inc. These players are focusing on expanding the business by adopting several strategies such as novel product development, collaborations, and mergers & acquisitions.
In September 2015, for instance, GlaxoSmithKline plc collaborated with Novartis AG to develop new drug vaccines. The company got the approval of two novel pediatric vaccines Infanrixin India and Boostrix from the vaccine division business.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2015 to 2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2026
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
KEY PLAYERS
- Johnson and Johnson
- Merck &Co., Inc.
- Sanofi Pasteur, Inc.,
- Emergent BioSolutions, Inc.
- Novartis AG
- Pfizer, Inc.
- GlaxoSmithKline Plc.
- CSL Ltd.
- Others
MARKET BY TYPE
- Subunit Vaccines
- Recombinant Vector Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Attenuated Vaccines
- DNA Vaccines
- Toxoid Vaccines
MARKET BY APPLICATION
- Cancer
- Infectious Diseases
- Autism
- Allergy
- Others
MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. VACCINES MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Type
2.1.2. Market Snippet by Application
2.1.3. Market Snippet by Region
2.2. Competitive Insights
3. VACCINES KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. VACCINES INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. VACCINES MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. VACCINES MARKET – BY TYPE
6.1. Overview
6.1.1. Segment Share Analysis, By Type, 2019 & 2026 (%)
6.2. Inactivated Vaccines
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3. Toxoid Vaccines
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4. Subunit Vaccines
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.5. Recombinant Vector Vaccines
6.5.1. Overview
6.6. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million) Overview
6.6.1. Segment Share Analysis, By Type, 2019 & 2026 (%)
6.7. Conjugate Vaccines
6.7.1. Overview
6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.8. DNA Vaccines
6.8.1. Overview
6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7. VACCINES MARKET – BY APPLICATION
7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
7.2. Cancer
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3. Infectious Disease
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.4. Allergy
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.5. Autism
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8. VACCINES MARKET– BY GEOGRAPHY
8.1. Introduction
8.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
8.2. North America
8.2.1. Overview
8.2.2. Key Manufacturers in North America
8.2.3. North America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.2.4. North America Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
8.2.5. North America Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
8.2.6. U.S.
8.2.6.1. Overview
8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.2.7. Canada
8.2.7.1. Overview
8.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3. Europe
8.3.1. Overview
8.3.2. Key Manufacturers in Europe
8.3.3. Europe Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.3.4. Europe Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
8.3.5. Europe Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
8.3.6. Germany
8.3.6.1. Overview
8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.7. Italy
8.3.7.1. Overview
8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.8. United Kingdom
8.3.8.1. Overview
8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.9. France
8.3.9.1. Overview
8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.10. Rest of Europe
8.3.10.1. Overview
8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Key Manufacturers in Asia Pacific
8.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.4.4. Asia Pacific Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
8.4.5. Asia Pacific Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
8.4.6. India
8.4.6.1. Overview
8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.7. China
8.4.7.1. Overview
8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.8. Japan
8.4.8.1. Overview
8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.9. South Korea
8.4.9.1. Overview
8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.10. Rest of APAC
8.4.10.1. Overview
8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5. Latin America
8.5.1. Overview
8.5.2. Key Manufacturers in Latin America
8.5.3. Latin America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.5.4. Latin America Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
8.5.5. Latin America Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
8.5.6. Brazil
8.5.6.1. Overview
8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5.7. Mexico
8.5.7.1. Overview
8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5.8. Argentina
8.5.8.1. Overview
8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5.9. Rest of LATAM
8.5.9.1. Overview
8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.6. Middle East and Africa
8.6.1. Overview
8.6.2. Key Manufacturers in Middle East and Africa
8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.6.4. Middle East and Africa Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
8.6.5. Middle East and Africa Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
8.6.6. Saudi Arabia
8.6.6.1. Overview
8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.6.7. United Arab Emirates
8.6.7.1. Overview
8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9. KEY VENDOR ANALYSIS
9.1. Johnson & Johnson
9.1.1. Company Snapshot
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. Merk & Co. Inc.
9.3. Sanofi Pasteur Inc.
9.4. Emergent BioSolutions, Inc.
9.5. Novartis AG
9.6. Pfizer Inc.
9.7. GlaxoSmithKline Plc.
9.8. CSL Limited
9.9. Others
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. References
11.3. Abbreviations
11.4. Disclaimer
11.5. Contact Us
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Vaccines market: Type Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Type
TABLE Global Vaccines market, by Type 2015-2026 (USD Million)
TABLE Vaccines market: Application Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Vaccines market, by Application 2015-2026 (USD Million)
TABLE Vaccines market: Regional snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Vaccines market, by Region 2015-2026 (USD Million)
TABLE North America Vaccines market, by Country, 2015-2026 (USD Million)
TABLE North America Vaccines market, by Type, 2015-2026 (USD Million)
TABLE North America Vaccines market, by Application, 2015-2026 (USD Million)
TABLE Europe Vaccines market, by country, 2015-2026 (USD Million)
TABLE Europe Vaccines market, by Type, 2015-2026 (USD Million)
TABLE Europe Vaccines market, by Application, 2015-2026 (USD Million)
TABLE Asia Pacific Vaccines market, by country, 2015-2026 (USD Million)
TABLE Asia Pacific Vaccines market, by Type, 2015-2026 (USD Million)
TABLE Asia Pacific Vaccines market, by Application, 2015-2026 (USD Million)
TABLE Latin America Vaccines market, by country, 2015-2026 (USD Million)
TABLE Latin America Vaccines market, by Type, 2015-2026 (USD Million)
TABLE Latin America Vaccines market, by Application, 2015-2026 (USD Million)
TABLE Middle East and Africa Vaccines market, by country, 2015-2026 (USD Million)
TABLE Middle East and Africa Vaccines market, by Type, 2015-2026 (USD Million)
TABLE Middle East and Africa Vaccines market, by Application, 2015-2026 (USD Million)
List of Figures
FIGURE Vaccines market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE Competitive Landscape; Key company market share analysis, 2018
FIGURE Type segment market share analysis, 2019 & 2026
FIGURE Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Inactivated Vaccines market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Toxoid Vaccines market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Attenuated Vaccines market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Subunit Vaccines market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Recombinant Vector Vaccines market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Conjugate Vaccines market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE DNA Vaccines market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Application segment market share analysis, 2019 & 2026
FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Infectious Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Allergy market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Autism market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Regional segment market share analysis, 2019 & 2026
FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE North America Vaccines market share and leading players, 2018
FIGURE Europe Vaccines market share and leading players, 2018
FIGURE Asia Pacific Vaccines market share and leading players, 2018
FIGURE Latin America Vaccines market share and leading players, 2018
FIGURE Middle East and Africa Vaccines market share and leading players, 2018
FIGURE North America Vaccines market share analysis by country, 2018
FIGURE U.S. Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Canada Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Europe Vaccines market share analysis by country, 2018
FIGURE Germany Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Spain Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Italy Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE UK Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE France Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of the Europe Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Asia Pacific Vaccines market share analysis by country, 2018
FIGURE India Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE China Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Japan Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE South Korea Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Singapore Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of APAC Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Vaccines market share analysis by country, 2018
FIGURE Brazil Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Mexico Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Argentina Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of LATAM Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Vaccines market share analysis by country, 2018
FIGURE Saudi Arabia Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE United Arab Emirates Vaccines market size, forecast and trend analysis, 2015 to 2026 (USD Million)
